Table 2 Association between single SNPs and MM risk.
From: Genetically determined telomere length and multiple myeloma risk and outcome
SNP | Gene | Allele | MAFa | EAa | Allelic modelb | Codominant modelc | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M/m | HR1 | 95% CI1 | Pvalue | HRHet | 95% CI | Pvalue | HRHom | 95% CI | Pvalue | ||||
rs11125529 | ACYP2 | C/A | 0.11 | A | 0.99 | 0.86–1.16 | 0.994 | 1.10 | 0.92–1.31 | 0.299 | 0.63 | 0.37–1.07 | 0.093 |
rs6772228 | PXK | T/A | 0.04 | T | 0.81 | 0.62–1.07 | 0.121 | 0.75 | 0.50–0.99 | 0.048 | 1.91 | 0.43–8.32 | 0.389 |
rs10936599 | TERC | C/T | 0.24 | C | 0.79 | 0.70–0.90 | 1.72 × 10−4 | 0.84 | 0.72–0.98 | 0.027 | 0.55 | 0.39–0.76 | 2.87 × 10−4 |
rs7675998 | NAF1 | G/A | 0.24 | G | 0.94 | 0.83–1.06 | 0.321 | 0.84 | 0.73–0.98 | 0.029 | 1.15 | 0.82–1.60 | 0.402 |
rs2736100 | TERT | A/C | 0.5 | C | 1.07 | 0.96–1.18 | 0.223 | 1.07 | 0.89–1.28 | 0.479 | 1.14 | 0.92–1.39 | 0.223 |
rs9420907 | OBFC1 | A/C | 0.13 | C | 1.17 | 1.03–1.35 | 0.020 | 1.32 | 1.12–1.55 | 7.78 × 10−4 | 0.88 | 0.57–1.35 | 0.556 |
rs3027234 | CTC1 | C/T | 0.22 | C | 0.89 | 0.79–1.00 | 0.054 | 0.97 | 0.83–1.13 | 0.669 | 0.65 | 0.47–0.90 | 0.009 |
rs8105767 | ZNF208 | A/G | 0.28 | G | 1.14 | 1.02–1.27 | 0.022 | 1.05 | 0.90–1.21 | 0.559 | 1.46 | 1.12–1.90 | 0.005 |
rs412658 | ZNF676 | C/T | 0.35 | T | 1.01 | 0.91–1.12 | 0.866 | 1.02 | 0.88–1.18 | 0.826 | 1.01 | 0.81–1.27 | 0.920 |
rs6028466 | DHX35 | G/A | 0.07 | A | 1.23 | 1.08–1.50 | 0.042 | 1.25 | 1.00–1.55 | 0.048 | 1.33 | 0.55–3.15 | 0.505 |
rs755017 | ZBTB46 | A/G | 0.12 | G | 1.10 | 0.93–1.29 | 0.235 | 1.05 | 0.88–1.25 | 0.609 | 1.61 | 0.88–2.93 | 0.120 |